This course will begin with a brief review of ocular surface disease, including definition, risk factors, and how to identify/diagnose. Followed by background on blepharitis (Demodex), chalazion, and hordeolum. Emphasis will be placed on both 1) modern in-office therapeutic options (i.e. MBE, Thermal Expression, IPL, Amniotic Membrane) as well as 2) updated pharmaceutical options (ie immunomodulators, recently FDA-approved ophthalmic therapies, and new drugs in the pipeline). We will also discuss managing blepharitis with glaucoma patients. If time allows, we will cover patient cases.

Speaker: Dr. Vin Dang

Date: Thursday, May 29, 2025

Time: 5:30 PM - 6:30 PM Pacific Time

Location: Virtual

Moderator: TBD

Cost: Free!

COPE ID: 97329-TD

Category: Trt/Mngmnt Ocular Disease

This event is COPE approved for 1 hour of CE credit.

Thank you to Tarsus Pharmaceuticals for providing an educational grant to support this event.

Source: woou.org/up-events/current-treatment-modalities-of-ocular-surface-disease-and-glaucoma-1